PlusVitech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.49M

  • Investors
  • 7

PlusVitech General Information

Description

Developer of pharmaceutical treatments designed for non-invasive genetic cancer detection. The company's therapies focus on small-molecule, monoclonal antibodies instead of painful and time-consuming tissue biopsies, enabling doctors to detect and treat cancers early.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Herreros, 33
  • Mairena del Alcor
  • 41510 Sevilla
  • Spain
+34 600
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Vertical(s)
Corporate Office
  • Calle Herreros, 33
  • Mairena del Alcor
  • 41510 Sevilla
  • Spain
+34 600

PlusVitech Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PlusVitech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 18-Dec-2025 $3.49M Completed Clinical Trials - Phase 1
5. Grant 16-May-2024 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator 26-Jul-2023 Completed Clinical Trials - Phase 1
3. Later Stage VC 17-Aug-2021 Completed Clinical Trials - Phase 1
2. Angel (individual) 18-Nov-2019 $218K $423K Completed Startup
1. Angel (individual) 16-Jan-2017 $205K $205K Completed Startup
To view PlusVitech’s complete valuation and funding history, request access »

PlusVitech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 5,960 $1.179946 $38.59 $38.59 1x $38.59 13.13%
To view PlusVitech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PlusVitech Patents

PlusVitech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026214846-A1 Nano-formulation process Pending 08-Apr-2025
WO-2026215278-A1 Nano-formulation process Pending 08-Apr-2025
WO-2022253748-A1 Combinations for the treatment of hpv Inactive 03-Jun-2021
WO-2022243430-A1 Treatment of acne Inactive 20-May-2021
WO-2022234110-A1 Gamma-aminobutyric acid derivatives for use in cancer therapy Inactive 07-May-2021 A61K31/197
To view PlusVitech’s complete patent history, request access »

PlusVitech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PlusVitech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
INNVIERTE SICC Government
MassChallenge Accelerator/Incubator
Capital Global Partners Venture Capital Minority
Homu Health Ventures Venture Capital Minority
3Fs (Spain) Angel Group Minority
You’re viewing 5 of 7 investors. Get the full list »

PlusVitech FAQs

  • When was PlusVitech founded?

    PlusVitech was founded in 2013.

  • Where is PlusVitech headquartered?

    PlusVitech is headquartered in Sevilla, Spain.

  • What is the size of PlusVitech?

    PlusVitech has 2 total employees.

  • What industry is PlusVitech in?

    PlusVitech’s primary industry is Biotechnology.

  • Is PlusVitech a private or public company?

    PlusVitech is a Private company.

  • What is PlusVitech’s current revenue?

    The current revenue for PlusVitech is .

  • How much funding has PlusVitech raised over time?

    PlusVitech has raised $4.5M.

  • Who are PlusVitech’s investors?

    INNVIERTE SICC, MassChallenge, Capital Global Partners, Homu Health Ventures, and 3Fs (Spain) are 5 of 7 investors who have invested in PlusVitech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process